ALan L Robin MD PA
Baltimore, Maryland, 21209, United States
NCT Number: NCT00522600
This study will be used to evaluate how patients put eye drops in their eyes and any problems that may arise from this activity. The information gathered will help identify common problems patients are having with putting in their eye medications. Then doctors can be better informed about the issues and provide better advice to their patients to overcome these problems.
Looking for future studies?
Notify MeAll sexes
Observational
Baltimore, Maryland, 21209, United States
Approximately 100 patients will take part in a one time procedure and survey as part of this project. After appropriate consent patients are asked to complete a short 2 page survey about themselves and their eye drops. Then a video recording will be made of the patient instilling eye drops in their habitual manner. The eye drops used will be sterile saline placed in either Travatan-like or Systane bottles to simulate the corresponding prescribed medication. The videos will be graded for instillation technique and combined with scoring of survey answers.
Patients will be asked to instill the drops to their left eye with their dominant hand as we expect this to be most difficult. Patients with severe (>20/200) vision loss will instill drops into their better seeing eye.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Robin, Alan L., M.D.
Indiv
Evaluation of Eye Drop Administration in Glaucoma Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06229379
Cardiovascular Diseases, Cataract
Guangzhou, Guangdong, China
View Trial DetailsNCT03402802
Adherence, Patient, Behavior
Baltimore, Maryland, United States
View Trial DetailsNCT01682460
Dry Eye Syndromes, Dry Eyes
Waterloo, Ontario, Canada
View Trial DetailsNCT00794170
Behavior, Eye Diseases
Atlanta, Georgia, United States
View Trial Details